Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.49
-0.33 (-4.84%)
Mar 31, 2025, 1:11 PM EDT - Market open

Company Description

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.

The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.

It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.

Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation
Pulmonx logo
Country United States
Founded 1995
IPO Date Oct 1, 2020
Industry Medical Devices
Sector Healthcare
Employees 291
CEO Steven Williamson

Contact Details

Address:
700 Chesapeake Drive
Redwood City, California 94063
United States
Phone 650 364 0400
Website pulmonx.com

Stock Details

Ticker Symbol LUNG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $19.00
CIK Code 0001127537
CUSIP Number 745848101
ISIN Number US7458481014
SIC Code 3841

Key Executives

Name Position
Steven S. Williamson Chief Executive Officer, President and Director
David A. Lehman J.D. General Counsel and Secretary
Geoffrey Beran Rose Chief Commercial Officer
Mehul Joshi Chief Financial Officer
Sri Radhakrishnan Chief Technical Officer
Lauren Cristina Vice President of Finance and Administration (U.S.)
Marcee M. Maroney Vice President of Marketing
Sarah Huber Vice President of Sales (U.S.)
Lisa Paul Chief People Officer
Jérôme Erath Senior Vice President and GM of Europe Middle-East & Africa

Latest SEC Filings

Date Type Title
Mar 20, 2025 144 Filing
Mar 3, 2025 144 Filing
Feb 25, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 25, 2025 10-K Annual Report
Feb 20, 2025 144 Filing
Feb 19, 2025 8-K Current Report
Feb 4, 2025 SCHEDULE 13G/A Filing
Jan 17, 2025 144 Filing
Jan 16, 2025 144 Filing
Nov 22, 2024 144 Filing